X0306 4 2018-03-12 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001719115 Griffin Deborah A C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 5 BASEL STREET PETACH TIKVA L3 4951033 ISRAEL 0 1 0 0 Chief Accounting Officer Ordinary Shares 2018-03-12 4 M 0 952 A 952 D Ordinary Shares 2018-03-12 4 S 0 952 19.489 D 0 D Restricted Share Units 2018-03-12 4 M 0 952 0.00 D Ordinary Shares 952 953 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.46 to $19.50, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Restricted share units were granted on March 12, 2015, with 952 vesting on March 12, 2018 and 953 vesting on March 12, 2019. /s/ Dov Bergwerk, as attorney-in-fact for Deborah A. Griffin 2018-03-14